...
首页> 外文期刊>Neurosurgery >Controversies in the endovascular management of cerebral vasospasm after intracranial aneurysm rupture and future directions for therapeutic approaches.
【24h】

Controversies in the endovascular management of cerebral vasospasm after intracranial aneurysm rupture and future directions for therapeutic approaches.

机译:颅内动脉瘤破裂后脑血管痉挛的血管内治疗争议以及治疗方法的未来方向。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cerebral vasospasm is one of the leading causes of morbidity and mortality after aneurysmal subarachnoid hemorrhage. Despite maximal medical therapy, however, up to 15% of patients surviving the ictus of subarachnoid hemorrhage experience stroke or death from vasospasm. For those cases of vasospasm that are refractory to medical treatment, endovascular techniques are frequently used, including balloon angioplasty with or without intra-arterial infusion of vasodilators, combined endovascular modalities, and aortic balloon devices. In this article, we review each of these therapies and their expanding role in the management of this condition. Moving forward, rigorous prospective outcome assessments after endovascular treatment of cerebral vasospasm are necessary to clearly delineate the efficacy and indications for these techniques.
机译:脑血管痉挛是动脉瘤性蛛网膜下腔出血后发病和死亡的主要原因之一。尽管进行了最大程度的药物治疗,但是,仍有多达15%的蛛网膜下腔出血幸存者幸免于中风或因血管痉挛死亡。对于那些难于接受药物治疗的血管痉挛的病例,经常使用血管内技术,包括在有或没有动脉内输注血管舒张剂的球囊血管成形术,联合的血管内形态和主动脉球囊装置。在本文中,我们回顾了这些疗法中的每一种及其在这种疾病管理中的扩展作用。今后,血管内治疗脑血管痉挛后必须进行严格的前瞻性评估,以明确描述这些技术的疗效和适应症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号